Vaccines for pandemic influenza

Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Date of authorisation: 02/06/2017, Revision: 8, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD+H5, avian influenza vaccine (live recombinant), Status: Authorised

EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 March 2025, 14:00 (CET) to 5 March 2025, 18:00 (CET)

Meeting report - EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins

Cancer Medicines Forum: September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 September 2025, 14:00 (CEST) to 4 September 2025, 17:00 (CEST)

Minutes of the Cancer Medicines Forum - September 2025

Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 11, Status: Authorised

Product Management Service (PMS) – Frequently Asked Questions (FAQs)

Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 19, Status: Authorised